A POTENTIAL BIOMARKER FOR GLIOBLASTOMA?

Glioblastoma is a aggressive brain cancer known for its quick growth and resistance to standard treatments. Research are constantly underway to identify new treatment strategies, and recently, a novel biomarker named LCA168 has emerged as a potential focus for glioblastoma treatment. LCA168 is a protein that is abundantly produced in GBM cells com